Home > News

News

Novartis AG v Dexcel Pharma Limited [2008] EWHC 1266 (Pat)10 June 2008In June 2008, Daniel Alexander QC and Mark Chacksfield acted for Novartis in obtaining an interim injunction in a patent dispute concerning one of Novartis’ leading products, NEORAL®, a cyclosporin formulation. The case involved the question of the extent to which the court was bound by an earlier court’s approach to interpretation of the claims […]
Actavis -v- Merck [2008] EWCA Civ 44421 May 2008Peter Prescott QC was leading counsel in the landmark case of Actavis v. Merck which aligned UK practice as regards Swiss-claims with that of the EPO. He persuaded the Court of Appeal to establish a new exception to the long-standing rule in Young v. Bristol Aeroplane (that a later court of appeal is bound by […]
Rolawn -v- Turfmech [2008] EWHC 989 (Pat)7 May 2008Daniel Alexander QC and Robert Onslow acted for the claimant and Andrew Lykiardopoulos acted for the defendant in Rolawn v. Turfmech in a trial before Mann J concerning the scope of design rights in giant lawn mowers for turf growing, raising issues of the nature of the aspects of shape and configuration protected by design […]
Buhler AG -v- FP Spomax [2008] EWHC 823 (Ch)21 April 2008A patent infringement and validity case heard in February 2008, regarding a patent for a new ‘double roller’ grinding process method of milling flour for starch. The Defendant alleged that the patent was invalid for obviousness. The Judge held that the patent was obvious. Andrew Lykiardopoulos appeared on behalf of the successful Defendant.
Abbott Laboratories v Evysio Medical Devices ULC [2008] EWHC 800 (Pat)21 April 2008The Defendant had three patents relating to coronary stents. The Claimant sought a declaration of non-infringement of these patents in relation to its own coronary stent. The Defendant counter-claimed for infringement. The Claimant challenged the validity of the patents claiming that the patents were obvious, insufficient, the claims were not entitled to priority and that […]